KeyCorp vs Kenvue Inc. Common Stock — how do they compare? KeyCorp trades at $19.97 (market cap $21.45B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KEY | KVUE | |
|---|---|---|
Market Cap | $21.45B | $34.06B |
Volume | 19,450,846 | 23,267,228 |
Sector | Financials | Consumer Staples |
52-Week High | $23.99 | $19.83 |
52-Week Low | $16.78 | $14.11 |
Typical Hold Time | 66 Days | — |
Enterprise Value | $34.63B | $41.56B |
Dividend Yield | 4.08% | 4.74% |
Signals from Pluang's Aura AI — not financial advice
KeyCorp (KEY) trades at $20.10, up 1.36% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows strong fundamentals with a P/E of 11.75, net income margin of 26.72%, and three consecutive quarterly earnings beats. Recent corporate actions include a dividend payment scheduled for September 2026 and key executive appointments in wealth and retail banking.
The outlook is supported by analyst consensus with a $25.00 price target and 60.79% buy ratings, though risks include volatile cash flows and competitive pressures. Revenue growth momentum and aggressive share buybacks provide upside potential, but investors should weigh the frozen dividend against peers and monitor interest rate impacts on net interest income.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →